Description: Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
Home Page: www.pahc.com
Glenpointe Centre East
Teaneck,
NJ
07666-6712
United States
Phone:
201 329 7300
Officers
| Name | Title |
|---|---|
| Mr. Jack Clifford Bendheim | Chairman, President & CEO |
| Mr. Glenn C. David | Chief Financial Officer |
| Mr. Larry L. Miller | Chief Operating Officer |
| Mr. Daniel M. Bendheim J.D. | Executive VP of Corporate Strategy & Director |
| Mr. Rob Aukerman | President of North America Region |
| Ms. Judith A. Weinstein | Senior VP, General Counsel & Corporate Secretary |
| Ms. Lisa A. Escudero | Senior Vice President of Human Resources |
| Mr. Jonathan Bendheim | President of MACIE Region, GM of Israel Operations & Director |
| Mr. Ramon Fuenmayor | President South America Region |
| Mr. Samson Li | President of Asia Pacific Region |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 10.3842 |
|---|---|
| Trailing PE: | 52.6829 |
| Price-to-Book MRQ: | 3.5822 |
| Price-to-Sales TTM: | 0.8437 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 1940 |